Ivana Basta

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

Paraskevi Zisimopoulou, Panagiota Evangelakou, John Tzartos et al. · Journal of Autoimmunity · 2013 · 317 citations · Full text

Autoimmune Disease, Medicine, Pathology +4

MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study

Anastasios Tsonis, Paraskevi Zisimopoulou, Konstantinos Lazaridis et al. · Journal of Neuroimmunology · 2015 · 79 citations · Full text

Autoimmune Disease, Musk Autoantibodies, Immunology +7

Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen

Christos Stergiou, Konstantinos Lazaridis, Vasiliki Zouvelou et al. · Journal of Neuroimmunology · 2016 · 71 citations

New Role, Autoimmune Disease, Immunology +6

Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)

Ivana Basta, Tatjana Pekmezović, Stojan Perić et al. · Neurological Sciences · 2012 · 66 citations

Quality Of Life, Family Medicine, Life Assessment +6